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A novel surgical approach to close an acute ventricular septal defect
using an occluder device
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Surgical treatment of an acute ischemic ventricular septaldefect (aVSD) is still associated with high morbidity andmortality. We report a novel surgical procedure to closean aVSD.
Clinical Summary
A 75-year-old man with an acute anterior myocardial infarction
was admitted to a peripheral hospital and transferred to our insti-
tution 4 days later with acute left heart failure and a grade 4
pansystolic murmur. On examination, he was tachypneic, with sinus
tachycardia and a blood pressure of 100/82 mm Hg. The chest x-ray
film showed signs of pulmonary edema. The echocardiogram
confirmed an anterior VSD (diameter 7-9 mm) with a left-to-right
shunt (pulmonary/systemic [Qp/Qs] shunt ratio 3.4:1, measured
with quantitative Doppler echocardiography). The right ventricle
was of normal size and function and the estimated systolic pulmo-
nary artery pressure (PAP) was 50 mm Hg (Figure 1). The left
ventricular ejection fraction was 45%.
The patient’s condition was stabilized with inotropic support
and an intra-aortic balloon pump. Coronary angiography showed
significant disease in the left anterior descending and right coro-
nary arteries.
Ethical approval for this new approach was sought from the
Novel Procedures Committee at our institution. After informed
consent, the patient was taken to theater 10 days after admission
because of worsening hemodynamics.
At operation ventricular function was found to be severely
impaired. The patient was placed on cardiopulmonary bypass
(CPB) with bicaval cannulation and revascularization was per-
formed on the beating heart using a sequential internal thoracic
artery to the left anterior descending and first diagonal branch and
sequential vein grafts to the branches of the right coronary artery.
An epicardial 3-dimensional echocardiogram showed the aVSD
with a diameter of 18 by 21 mm in the mid septum. An attempt to
insert the occluder device (Amplatzer; AGA Medical Corp,
Golden Valley, Minn) into the aVSD via a puncture of the right
ventricle failed owing to insufficient tactile feedback to the sur-
geon. Therefore, total CPB was established, ventricular fibrillation
was induced, and the right ventricle was opened with a 2-cm
incision in the anterior wall directly above the aVSD. The
aVSD showed a size of 20 mm. An Amplatzer muscular oc-
cluder device of 24 mm (oversized by 10% to 20% as recom-
mended by the manufacturer) was used. Because the deployment
catheter of the device is produced for a percutaneous approach
(1 m in length), the surgeon controlled the device at the tip of the
guiding catheter and the first assistant controlled the end of the
deployment catheter. After the device was deployed and its posi-
tion confirmed (Figure 2), the right ventricle was closed with 4-0
Prolene polypropylene suture (Ethicon, Inc, Somerville, NJ) with
pericardial pledgets. Retained air from the left and right sides of
the heart was removed and the patient was weaned from CPB
with intra-aortic balloon pump support and norepinephrine
(0.09 g · kg1 · h1) infusion. Intraoperative echocardiography
showed the device well seated across the aVSD, with residual flow
through the center of the device.
The patient was extubated 12 hours after the operation and
weaned from inotropic agents over the next 10 days. The patient’s
recovery was delayed by a right-sided hemothorax resulting from
aspiration of a pleural effusion, which required chest drainage. He
was subsequently discharged home mobilizing independently 32
days after the operation. His estimated PAP decreased to 30 mm Hg.
The shunt size was calculated as 2:1 (Qp/Qs) at discharge. Now,
at 6 months’ follow-up, the systolic PAP was estimated to be
20 mm Hg, shunt size unchanged, and the patient was asymp-
tomatic.
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Figure 1. Five-chamber apical view showing site of ventricular
septal defect (VSD). LV, Left ventricle; LA, left atrium; RV, right
ventricle; RA, right atrium; AV, aortic valve. Markers on side of
image are 1 cm apart.
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Discussion
Postinfarction aVSD is an uncommon event that typically occurs
during the first week after myocardial infarction and is associated
with high morbidity and mortality with survivals of close to zero
in conservatively managed cases. Early conventional surgery, usu-
ally performed with a prosthetic patch to close the VSD, has been
shown to improve survival; however, even in selected patients
in-hospital survivals are only around 50%.1
There is little in the literature concerning interventional ap-
proaches using an occluder device for postinfarction aVSDs, al-
though use of such devices is a well-established method of closure
for congenital defects.2-4 Holzer and associates4 reported promis-
ing results using percutaneously placed occluder devices in isch-
emic VSDs in 18 patients; however, only 5 patients were treated in
the acute setting, in which placement of the device was more
complicated.4 Residual flow through the device has been previ-
ously reported and has been found to diminish over time owing to
coagulation of blood in the device.5
This novel surgical approach is a new option in the treatment of
aVSDs. An incision in the infarcted left ventricle is avoided, it can
be performed on the beating heart to avoid further ischemia, and it
allows placement of the device under direct vision. The limitation
of this procedure is the persistent shunt through the device. It is
suggested here that development of improved devices could result
in even better outcomes. Possible techniques to deal with this
residual flow could be the instillation of BioGlue (CryoLife, Inc,
Kennesaw, Ga) into the device itself or securing a pericardial patch
to cover the mesh on the right ventricular side of the device.
Further cases are required to assess short- and long-term efficacy
compared with conventional surgical closure before widespread
use of this technique could be recommended.
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Figure 2. Four-chamber apical view showing position of ventric-
ular septal occluder device in ventricular septum. LV, Left ven-
tricle; LA, left atrium; RV, right ventricle; RA, right atrium.
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